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1. Introduction 
Microtubules and microfilaments have been shown 
to be involved in the secretion processes of many 
glands: thyroid gland [ 11, pancreatic islets [2], adrenal 
medulla [3], anterior pituitary [4], parotid gland [ 51 
and exocrine pancreas [6,7]. Most of these studies 
used drugs known to alter the structure of these cellu- 
lar organelles. On the other hand, microtubules as 
well as microfilaments have been implicated in the 
control of the redistribution and motility of mem- 
brane surface components [8-l 21. Furthermore, 
recent studies suggested that microtubules and/or 
microfilaments are probably involved in the process 
of adenylate cyclase stimulation by hormones [ 13,141. 
In pancreatic acinar cells the initial step in the 
sequence of events mediating the action of secreta- 
gogues is an increase in intracellular guanosine 3’:5’ 
cyclic monophosphate (cyclic GMP) [ 15 ,161. Further, 
microtubules and microfilaments were shown to be 
widely distributed in these cells [7]. Thus the present 
study was undertaken in order to investigate the pos- 
sible role of microtubules and microfilaments in the 
secretagogue-induced cyclic GMP accumulation by rat 
exocrine pancreas. We report that both vinblastine 
which causes the disappearance of microtubules 
[ 7,171, and cytochalasin B which impairs the func- 
tion of microfilaments [7,18] inhibit the cyclic GMP 
response of rat exocrine pancreas to peptide hormones 
(caerulein), cholinergic agents (carbachol) or the cal- 
cium ionophore A 23 187. 
2. Materials and methods 
Pancreata were taken from 2.5-month-old male 
Wistar rats as previously described [ 191. The incuba- 
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tions were performed at 37°C in a Krebs-Ringer bicar- 
bonate medium supplemented with 10 mM D-glucose 
and the amino acid mixture of Campagne and Gruber 
[ 191 under a 95% Oa, 5% CO* atmosphere. The pan- 
creatic fragments (about 50 mg wet weight) were 
treated for 1,2,5, 10 or 30 min with 3 X lo-” M 
caerulein, lOwe’ M carbachol or lo-’ M ionophore 
A 23187, in the presence or absence of vinblastine or 
cytochalasin B. Timed,incubations were terminated 
by quickly removing the fragments, instant freezing 
in liquid Nz and homogenization in 2 ml of ice-cold 
6% trichloroacetic acid. After centrifugation at 0°C of 
the acidified homogenate, the acid-soluble supernatant 
was collected, extracted twice with 10 vol. of water- 
saturated ether and assayed for cyclic GMP content 
using a commercially available protein-binding assay 
(Boehringer Test Kits, Mannheim, Germany). Recov- 
ery (80-90%) was monitored with 1 nCi of [3H] cyclic 
GMP and the specificity of the assay was checked by 
the cyclic phosphodiesterase test (201. The acid-pre- 
cipitable material was dissolved in 2.0 ml of 1 N 
NaOH and assayed for protein content by the method 
of Lowry et al. [21]. In parallel experiments, the pan- 
creatic fragments were preincubated for 15,30,60 or 
120 min in the presence of vinblastine or cytochalasin 
B before the cyclic GMP response to secretagogues 
was measured. 
Results are expressed as the mean of 4 to 6 repli- 
cates in pmol/mg of protein. Similar results were 
obtained when samples were purified on a column of 
Dowex AGlX8. However, in the majority of experi- 
ments, the cyclic GMP concentration was determined 
without the prior column step since this procedure 
was found to give the most consistent results. 
Caerulein was a generous gift from Farmitalia 
(Milan, Italy). Carbachol was obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). Ionophore 
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A 23187 and vinblastine sulphate (Velbe) were a 
generous gift from Eli Lilly (St. Cloud, France). 
Cytochalas~ B was purchased from EGA Chemie 
(Steinheim Albuch, W. Germany) and 3-isobutyl-l- 
methyl xanthine (MIX) from Aldrich Chemical Co. 
(Milwaukee, WI, USA). 
3. Results 
As shown in fig.1, 3 X lo-** M caerulein, 10T6 M 
carbachol and lo-’ M ionophore A 23187, induced a 
rapid and transient accumulation of cellular cyclic 
GMP in pancreatic fragments. This increase was maxi- 
mal (8- to IO-fold over the basal value} after 2 min 
and then decreased steadily toward control values by 
30 min. 
vinblastine had no significant effect when introduced 
at the beginning of the incubation along with the 
secretagogues (flg.2A and fig.1) and a 15-30 min 
preincubation with the drug was necessary for 
decreasing significantly the response to caerulein 
(fig.2A). The vinblastine-induced refractoriness was 
maximal at 5 X lo-’ M for a 60 min preincubation, 
but a dose as low as 5 X IO-’ M was sufficient for 
eliciting the loss of responsiveness to caerulein 
(lig2B). 
In contrast, pancreatic fragments pretreated with 
5 X 10-s M vinblastine for 60 min were no longer 
responsive to either caerulein, carbachol or ionophore 
A 23187, whereas the basal cyclic GMP levels were 
not signi~cantly affected. This vinblastine-mediated 
inhibitory effect depended on dose and duration of 
the treatment with the drug. Fig.2 shows the relative 
effects of both parameters on the cyclic GMP accu- 
mulation in response to caerulein. At 5 X lo-’ M 
Cytochalasin B was similarly studied. At 2 X lo-’ M 
cytochalasin B also abolished the cyclic GMP response 
to either caerulein, carbachol or ionophore, without 
altering the basal levels of this cyclic nucleotide (fig.1). 
In contrast to vinblastine, cytochalasin B was imme- 
diatly effective without preincubation (fig.3A). This 
refractoriness was maintained even after a 2-h prein- 
cubation with the drug. Fig.3B depicts the effect of 
different concentrations of cytochalasin B on the 
caerulein-induced cyclic GMP accumulation without 
preincubation with the drug: A dose as low as 
2 X lo-’ M was sufficient for eliciting a 50% inhibi- 
tion of the response to caerulein. 
The suppression of the cyclic GMP response to 
caerulein, carbachol and ionophore A 23 187 by either 
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Fig.1. Time course of cyclic GMP accumulation in rat exocrine pancreatic fragments exposed to 3 X 10-‘0 M caerulein, 10e6 M 
carbachol or 10-s M ionophore A 23187. Secretagogues were added without (O-O), or with 2 X 10m5 M cytochalasin B 
(=--.) or 5 x lo-’ M vinblastine (a----b). The cyclic GMP response of pancreatic fragments pretreated for 60 min with 
5 X 10m5 M vinblastine (A-A), was studied in parallel. Unstimu~t~ controls (o---o) were run with hormone or ionophore 
solvents, 5 X 10e5 M vinbtastine, or 2 X lo-” M cytochalasin B. 
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Fig.2. (A) Cyclic GMP response to 3 x 10-r’ M caerulein of pancreatic fragments pretreated for various periods of time with 
5 x lo-’ M vinblastine. The cyclic GMP levels were measured 2 mm after the addition of 3 X lo-*’ M caerulein. Control values 
represent he increase in the cyclic GMP content of untreated cells which were exposed for 2 min to caerulein. (B) Response of 
pancreatic fragments to 3 X lo-“’ M caerulein following a 60 min pretreatment with graded doses of vinblastine. The intracellular 
cyclic GMP content was measured 2 min after the exposure to 3 X lo-“’ M caerulein. 
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Fig.3. Cyclic GMP response to 3 X lo-“’ M caerulein of pancreatic fragments pretreated for various periods of time with 2 X lo-’ M 
cytochalasin B (A), or treated with graded doses of cytochalasin B without preincubation (B). The intracellular cyclic GMP con- 
centration was determined 2 min after the addition of 3 X lo-“’ M caerulein. 
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Tabie 1 
Effect of l-methyl-3-~sobutylxanthine (MIX), on the 
vinblastine and cytochalasin B-mediated suppression of cyclic 
GNP accumulation 
-~___ 
Cyclic GMP (pmol/mg protein) 
No MIX 0.5 mM MIX 
-- -~- 
Controls 1.16 ?r 0.10 1.54 2 0.39 
VB 1.18 * 0.48 1.40 + 0.50 
CB 0.88 f 0.26 1.43 * 0.18 
Caerulein 3.55 + 0.61 4.66 + 0.14 
Caerulein + VB 1.29 f 0.10 1.69 + 0.21 
Caerulein + CB 1.43 -r 0.25 1.82 t- 0.31 
Carbachol 4.93 + 0.13 5.53 i 1.48 
Carbachol + VB 1.51 * 0.19 1.25 i 0.14 
Carbachol + CB 1.38 i 0.04 1.08 c 0.13 
Ionophore A 23187 4.17 + 0.24 5.08 * 1.24 
Ionophore A 23187 f VB 2.14 i 0.39 1.31 r 0.07 
Ionophore A 23187 + CB 2.67 + 0.16 1.26 * 0.13 
Rat exocrine pancreatic fragments were pretreated for 60 min 
with 5 X lo-’ M vinblastine (VB) or treated with 2 X lo-’ M 
cytochalasin B (CB) without preincubation; then the intracel- 
lular cyclic GMP concentration was determined 2 mm after 
the addition of 3 X lo-” M caerulein, 1Om6 M carbachol or 
lOWA M ionophore A 23187 with or without 0.5 mM MIX 
vinblastine or cytochalasin B was not modified when 
both drugs were combined (data not shown). 
It should be stressed that the addition of 0.5 mM 
MIX, a potent cyclic nucleotide phosphodiesterase 
inhibitor, did not overcome the vinblastine and cyto- 
chalasin B-mediated suppression of the cyclic GMP 
response in rat pancreatic fragments (table 1). 
4. Discussion 
Although the cellular mechanism of action of secre- 
tagogues uch as caerulein, carbachol and calcium 
ionophore A 23 187 is not yet clear, the first step of 
their action is well established: caerulein and car- 
bachol primarily bind to a receptor present in the 
plasma membrane of pancreatic exocrine cells 
[22-241 whereas ionophore A 23 187 would facilitate 
the movement of divalent cations across biological 
membranes including plasma membrane [ 251. This 
first step is followed, through a mechanism which still 
has to be clarified, by a rapid and transient accumu- 
lation of cyclic GMP. 
Our results show that vinblastine and cytochalasin 
B inhibit the cyclic GMP response to caerulein, car- 
bachol and ionophore A 23187. ~ytoch~asin B was 
338 
immediately effective, whereas vinblastine needed 
15-30 min to exert a significant effect. 
These drugs might alter the binding of caerulein 
and carbachol to their receptor sites and/or impair a 
coupling mechanism between the hormone-receptor 
complexes and guanylate cyclase which has been 
localized in the apical plasmalemma membrane of the 
pancreatic acinar cell [26]. However, these suggestions 
could not be ascertained since the calcium ionophore 
A 23 187-induced cyclic GMP accumulation was simi- 
larly inhibited. 
The inhibitory effect of vinblastine and cytochala- 
sin B on the cyclic GMP response could be manifested 
through a decrease in the rate of production of cyclic 
GMP or an increase in its rate of hydrolysis. Although 
we did not measure guanylate cyclase activity in mem- 
brane preparations from vinblastine or cytochalasin 
B-treated pancreatic fragments, the inability of both 
drugs to affect the basal cyclic GMP levels even after 
a 2-h treatment argue against the possibility that 
guanylate cyclase was directly affected. On the other 
hand, since the addition of MIX failed to restore the 
normal response to caerulein, carbachol and ionophore 
A 23 187 in vinbiastine and cytochalasin B-treated 
pancreata, the possibility that an increased breakdown 
of cyclic GMP could account for the observed lack of 
responsiveness eems unlikely. Further, neither vin- 
blastine, or cytochalasin B enhanced the effl ux or 
hormone-elevated intracellular cyclic GMP (data not 
shown). 
Since guanylate cyclase activation has been reported 
to be calcium-dependent [27], the vinblastine and 
cytochalasin B-mediated refractoriness could result 
from alterations in calcium fluxes. Although previous 
studies have shown that neither cytochalasin 3 [6] nor 
vinblastine (H, Bauduin, personal communication) 
altered the calcium exchanges between the extracellu- 
lar mediunl and the pancreatic tissue, an effect of the 
drugs on the intracellular movements could not be 
ruled out. 
Under our experimental conditions, a damaging 
effect of vinblastine and cytochalasin B on the pan- 
creatic tissue seems unlikely. Neither drugs altered 
significantly the basal release of amylase and lipase 
[6,19,28], nor did they cause any leakage of lactic 
dehydrogenase (a cytoplasmic marker) in the extra- 
cellular medium [28]. Further the morphological 
integrity of acinar cells after exposure to vinblastine 
or ~ytoch~asin B has been evidenced by electron 
microscopy [C&7]. 
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An alternative candidate for the vinblastine and 
cytochalasin B-mediated refractoriness would be the 
microtubule-microfilament system. Such an argument 
is based on the observation that the inhibition of the 
cyclic GMP response to hormones, as the disappear- 
ance of microtubules and microfilaments in vinblastine 
and cytochalasin B-treated pancreas show similar time 
courses [7]. The time-dependence of the vinblastine 
effect could be due to limitation of the rate of entry 
of the drug into the cells, or to limitation of the rate 
of its binding to tubulin. 
Guanylate cyclase has been localized in the plas- 
malemma membrane of the pancreatic cells [26], but 
the nature of the cytoskeleton links to the plasma 
membrane that influence guanylate cyclase remains 
unclear and intriguing. In many systems, cytochalasin 
B has been shown to bind to plasma membranes 
[29,30] and microfilaments have been demonstrated 
in association with plasma membranes [ 121. On the 
other hand, although vinblastine-binding activity 
has been described for plasma membrane [31], micro- 
tubular structures have been generally observed in the 
cytoplasm [7] and their association with plasma 
membranes remains questionable [ 11,121. Since both 
drugs have a common effect on the cyclic GMP 
response, despite two different sites of action, it could 
be postulated that microtubules are linked to micro- 
filaments which are associated with the membrane 
[32]. Alteration of the latter either directly by 
cytochalasin B, or via the perturbation of the former 
by vinblastine, would cause a change in the membrane 
reflected in the behavior of guanylate cyclase. 
From our results, it seems that microfilaments and 
microtubules (cytoplasmic microtubules or vinblastine 
sensitive structures) are involved in guanylate cyclase 
stimulation by caerulein, carbachol and ionophore 
A 23 187. However, further work is necessary to learn 
the mechanism by which the microfilament-micro- 
tubule system is implicated in the process of guanylate 
cyclase stimulation. 
References 
[l] Neve, P., Willems, C. and Dumont, J. E. (1970) Exp. 
Cell Res. 43,457-460. 
[2] Lacy, P. E., Howell, S. L., Young, D. A. and Fink, C. J. 
(1968) Nature (Land.), 219, 1177-1179. 
[3] Poisner, A. M. and Bernstein, J. (1971) J. Pharmacol. 
Exp. Ther. 177,102-107. 
[4] Khar, A., Kunert-Radek, J. and Jutisz, M. (1979) FEBS 
Lett. 104,410-414. 
(51 
[61 
[71 
PI 
[91 
[lOI 
[Ill 
[I21 
1131 
iI41 
1151 
(161 
1171 
1181 
1191 
Butcher, F. and Colman, R. H. (1972) Biochem. 
Biophys. Res. Commun. 48, 23-29. 
Bauduin, H., Stock, C., Vincent, D. and Grenier, J. F. 
(1975) J. Cell. Biol. 66, 165-181. 
Stock, C., Launay, J. F., Grenier, J. F. and Bauduin, H. 
(1978) Lab. Invest. 38, 157-164. 
Edelman, G. M., Yahara, I. and Wang, J. L. (1973) Proc. 
Natl. Acad. Sci. USA 70, 1442-1446. 
De Penis, S. (1975) J. Cell. Biol. 65, 123-146. 
Nicolson, G. L. (1976) Biochim. Biophys. Acta 457, 
57-108. 
Berlin, R. D. (1975) Ann. N. Y. Acad. Sci. 253, 
445-454. 
Yahara, I. and Edelman, G. M. (1975) Ann. N. Y. Acad. 
Sci. 253,455-469. 
Zor, U., Strulovici, B. and Lindner, H. R. (1978) 
Biochem. Biophys. Res. Commun. 80,983-992. 
Rudolph, S. A., Greengard, P. and Malawista, S.E. 
(1977) Proc. Natl. Acad. Sci. USA 74,3404-3408. 
Haymovits, A. and Scheele, G. A. (1976) Proc. Natl. 
Acad. Sci. USA 73, 156-160. 
Christophe, J. P., Frandsen, E. K., Coulon, T. P., Krishna, 
G. and Gardner, J. D. (1976) J. Biol. Chem. 251, 
4640-4645. 
Borisy, G. G. and Taylor, E. W. (1967) J. Cell. Biol. 34, 
525-533. 
Wessells, N. K., Spooner, B. S., Ash, J. F., Bradley, 
M. O., Luduena, M. A., Taylor, E. L., Wrenn, J. T. and 
Yamada, K. M. (1971) Science 171,135-143. 
Launay, J. F., Stock, C. and Grenier, J. F. (1979) Exp. 
CelI Res. 118,171-180. 
[20] Rochette, C. and Castagna, M. (1977) Biochem. 
Biophys. Res. Commun. 74,1287-1296. 
[21] Lowry, 0. J., Rosebrough, N. J., Farr, A. L. and 
Randall, R. J. (1951) J. Biol. Chem. 193,265-275. 
[22] Deschodt-Lanckman, M., Robberecht, P., Camus, J. and 
Christophe, J. (1978) Eur. J. Biochem. 91,21)29. 
[ 231 Christophe, J., De Neef, P., Deschodt-Lanckman, M. 
and Robberecht, P. (1978) Eur. J. Biochem. 91, 31-38. 
1241 Devine Strader, C. B., Revel, J. P. and Raftery, M. A. 
(1979) J. Cell Biol. 83,499-510. 
[25] Matsuzawa, H. and Nirenberg, M. (1975) Proc. Natl. 
Acad. Sci. USA 74,3472-3476. 
[26] Kappor, C. L. and Krishna, G. (1977) Science 196, 
1003-1005. 
[27] Murad, F., Arnold, W. P., Mittal, C. K. and Braughler, 
J. M. (1979) Adv. Cycl. Nucl. Res. 11, 175-204. 
[28] Stock, C., Launay, J. F. and Grenier, J. F. (1977) 
Biochem. Biophys. Res. Commun. 76,217-223. 
[29] Mayhew, E., Poste, G., Cowden, M., Tolson, N. and 
Maslow, D. (1974) J. Cell Physiol. 84,373-382. 
[30] Riordan, J. F. and Alon, N. (1977) Biochim. Biophys. 
Acta 464,547-561. 
[31] Bhattacharyya, B. and Wolff, J. (1975) J. Biol. Chem. 
250,7639-7646. 
[32] Carraway, K. L., Doss, R. C., Huggins, J. W., Chesnut, 
R. W. and Carraway, C. A. C. (1979) J. Cell. Biol. 83, 
529-543. 
339 
